Genfit S.A. Return on Equity

Genfit S.A. (GNFTY) currently reports a ROE of -16.1%. That is below the Healthcare sector average of 20.77%. Use the charts on this page to explore Genfit S.A.'s ROE history and peer comparisons.

Genfit S.A.'s ROE of -16.1% is lower than the Healthcare sector average of 20.77%. That is roughly 177.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Genfit S.A.'s current -16.1% should be judged against Healthcare norms (sector average: 20.77%) and against GNFTY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -16.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for Genfit S.A., and consider following GNFTY for alerts when major investors trade the stock.

Genfit S.A. is classified in the Healthcare sector. On ROE, it currently shows -16.1% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNFTY with unrelated industries.